Eastman Chemical Company (EMN US)
EMN US$67.93
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 67.93
- Change
- ▲ 1.26 (1.89)
- Bid / Ask
- 67.93 - 67.98
- Volume
- 486,679
- Turnover
- 27,656,654
- Open
- 67.20
- Day Range
- 66.63 - 68.09
- VWAP
- 67.87
- Prev Close
- 66.67
- Last Trade
- 29/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Basic Materials
- Shares Issued
- 114,377,421
- NTA/Share
- 12.29
- Last Dividend
- 0.84
- Dividend Ex Date
- 15 SEP 2026
- Dividend Pay Date
- 7 OCT 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 8,752.00
- EBITDA
- 1,289.00
- Profit
- 474.00
- Earnings Per Share (EPS)
- 4.10
- Dividend Per Share (DPS)
- 3.33
- Yield %
- 5.04
- Market Cap
- 7,766.21
- Price to Earnings Ratio (P/E)
- 17.69
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 9,192.54
- EBITDA
- 1,643.12
- Profit
- 768.63
- Earnings Per Share (EPS)
- 6.76
- Dividend Per Share (DPS)
- 3.40
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- None
- Financial Health
- Moderate
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 73.55 Fair value 81.62 One-star price 90.57
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 81.62
- Price / Fair Value
- 0.82
- Valuation
- Undervalued
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 28 OCT 2026. The slider runs from the five-star price (73.55) to the one-star price (90.57).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 66.67 |
| Price - 12 month high | 83.47 |
| Price - 12 month low | 56.11 |
| Pricing date | 27 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 1.56 |
| Market capitalization | 7,622.16 |
| 12 Month High price date | 12 FEB 2026 |
| 12 Month Low price date | 20 NOV 2025 |
| Volume - avg. trading volume for the last 3 months | 1.21 |
| Price - 1 Day % Change | 0.83% |
| Price - 13 week price percent change | -2.16% |
| Price - 26 week price percent change | -6.92% |
| Price - 5 Day % Change | 4.99% |
| Price - 52 week price percent change | 5.22% |
| Price - YTD price percent change | 3.64% |
| Price % Change Month To Date | 0.30% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 4.100 |
| EPS excluding extraordinary items - trailing 12 month | 3.830 |
| EPS Normalized - most recent fiscal year | 5.420 |
| Revenue/share - most recent fiscal year | 75.709 |
| Revenue/share - trailing 12 month | 77.087 |
| Book value per share - most recent fiscal year | 52.245 |
| Book value per share - most recent quarter | 53.321 |
| Book value (tangible) per share - most recent fiscal year | 12.288 |
| Book value (tangible) per share - most recent quarter | 13.908 |
| Cash per share - most recent fiscal year | 4.961 |
| Cash per share - most recent quarter | 6.044 |
| Cash Flow per share - most recent fiscal year | 9.291 |
| Cash Flow per share - trailing 12 month | 10.322 |
| Dividend per share - most recent fiscal year | 3.330 |
| Dividends per share - trailing 12 month | 3.360 |
| EBITD per share - trailing 12 month | 11.078 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 4.140 |
| EPS Basic excluding extraordinary items - trailing 12 month | 3.880 |
| EPS including extraordinary items - most recent fiscal year | 4.140 |
| EPS including extraordinary items - trailing 12 month | 3.880 |
| Free Cash Flow per share - trailing 12 month | 6.391 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 17.41 |
| P/E Normalized, most recent fiscal year | 13.47 |
| Price to sales - most recent fiscal year | 0.86 |
| Price to Tangible Book - most fiscal year | 5.04 |
| Price to Free Cash Flow per Share - most recent fiscal year | 10.43 |
| Price to Cash Flow per share - trailing 12 month | 6.46 |
| Price to Book - most recent fiscal year | 1.25 |
| P/E excluding extraordinary items high, trailing 12 months | 22.47 |
| P/E excluding extraordinary items low, trailing 12 months | 8.37 |
| Net Debt, LFI | 4,526.00 |
| Net Debt, LFY | 4,221.00 |
| Dividend Yield - 5 Year Average | 3.63% |
| Dividend Yield - indicated annual dividend divided by closing price | 5.08% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 5.04% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 528.00 |
| LT debt/equity - most recent fiscal year | 69.59% |
| Payout ratio - most recent fiscal year | 81.22% |
| Total debt/total equity - most recent fiscal year | 79.29% |
| LT debt/equity - most recent quarter | 72.10% |
| Total debt/total equity - most recent quarter | 84.49% |
| Free Cash Flow - trailing 12 month | 735.00 |
| Payout ratio - trailing 12 month | 130.81% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 8,752.00 |
| Revenue - trailing 12 month | 8,865.00 |
| EBITD - most recent fiscal year | 1,289.00 |
| EBITD - trailing 12 month | 1,274.00 |
| Earnings before taxes - most recent fiscal year | 568.00 |
| Earnings before taxes - trailing 12 month | 538.00 |
| Net Income available to common - most recent fiscal year | 474.00 |
| Net Income available to common - trailing 12 months | 442.00 |
| Earnings before taxes Normalized - most recent fiscal year | 698.00 |
| Net Income Available to Common, Normalized - most recent fiscal year | 627.00 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 4.95 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 5.43% |
| Net Profit Margin % - trailing 12 month | 5.00% |
| Operating margin - 1st historical fiscal year | 10.92% |
| Operating margin - trailing 12 month | 10.06% |
| Pretax margin - trailing 12 month | 6.07% |
| Pretax margin - 1st historical fiscal year | 6.49% |
| Operating Margin - 5 year average | 13.32% |
| Pretax Margin - 5 year average | 9.87% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 5.89% |
| Free Operating Cash Flow/Revenue, TTM | 8.29% |
| Net Profit Margin - 5 year average | 8.13% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 3.16% |
| Return on average assets - trailing 12 month | 2.93% |
| Return on average equity - most recent fiscal year | 8.13% |
| Return on average equity - trailing 12 month | 7.47% |
| Return on average assets - 5 year average | 5.17% |
| Return on average equity - 5 year average | 13.93% |
| Net Income/employee - most recent fiscal year | 36,538.46 |
| Revenue/employee - most recent fiscal year | 673,230.77 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 0.65% |
| EPS growth rate, 5 year | 3.22% |
| Growth rate% - dividend, 3 year | 2.75% |
| Revenue/share (5 yr growth) | 4.05% |
| Growth rate% - Revenue, 3 year | -6.13% |
| Growth rate% - EPS, 3 year | -13.57% |
| Book value per share growth rate, 5 year | 3.34% |
| Capital Spending growth rate, 5 year | 6.63% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | -0.38% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Eastman Chemical is a global specialty chemicals company that was incorporated in 1920 and spun out from Eastman-Kodak in 1994. It is headquartered in Kingsport, Tennessee, and reports four segments: additives and functional products, or AFP; advanced materials, or AM; chemical intermediates, or CI; and fibers. The company generates most of its sales outside of the US, with a strong presence in Asian and European markets.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
